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Abstract
Background: we aimed to develop and validate a population-representative 10-year mortality risk index for older adults in
England.
Methods: data were from 10,798 men and women aged 50 years and older in the population-based English Longitudinal
Study of Ageing in 2002/03, randomly split into development (n = 5,377) and validation cohorts (n = 5,421). Participants
were asked about their sociodemographics, health behaviours, comorbidities, and functional status in the home-based inter-
views. Variables that were independently associated with all-cause mortality through March 2013 in the development cohort
were weighted relative to one another to develop risk point scores for the index that was calibrated in the validation cohort.
Results: the validated 10-year mortality risk index assigns points for: increasing age (50–59 years: 0 points; 60–64: 1 point;
65–69: 3 points; 70–74: 5 points; 75–79: 7 points; 80–84: 9 points; ≥85: 12 points), male (2 points), no vigorous physical
activity (1 point), smoking (2 points), having a diagnosis of cancer (1 point), chronic lung disease (2 points) or heart failure
(4 points), and having difﬁculty preparing a hot meal (2 points), pushing or pulling large objects (1 point) or walking 100
yards (1 point). In the full study cohort, 10-year mortality rates increased from 1.7% (11/664) in those with 0 points to
95% (189/199) among those with ≥16 points.
Conclusion: this highly predictive 10-item mortality risk index is valid in the English population aged 50 years and older. It
uses simple information that is often available in research studies and patient reports, and does not require biomarker data
to predict mortality.
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Introduction
As the age structures of global populations shift upwards,
the ability to predict mortality risk for older adults becomes
increasingly valuable in clinical, research and policy settings.
Risk prediction scores are used extensively in the cardiovas-
cular context, but the plethora of cardiovascular risk calcu-
lators remain invalidated and are restricted to a single
clinical category [1, 2]. Mortality risk calculators have
broader applicability, such as aiding older patients and their
physicians in making decisions informed by precise estima-
tions about remaining life expectancy [2–4]. In epidemio-
logical research, mortality risk could be adjusted in
observational and randomised studies, examined in relation
to exposures or treatments, or compared across sociodemo-
graphic groups to assess social inequalities. For these uses
to be achievable, an appropriate mortality risk index for
older adults should include information that is readily
accessible through physician–patient discussion and regu-
larly collected in epidemiological studies. Such an index
would be particularly valuable in instances when biomarker
data are not readily available.
A 4- and 10-year mortality risk index has been devel-
oped for the general population of adults aged 50 years and
older in the USA [5, 6]. It assigns a set number of points to
a person based on his/her sociodemographic (age and sex),
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comorbid (diagnoses of cancer, diabetes, heart failure and
lung disease), health behaviour (current smoking) and func-
tional (activities of daily living) characteristics [5]. An indivi-
dual’s point score corresponds with his/her risk of 4- and
10-year mortality. However, this index is poorly calibrated
to the older English population, where life expectancy is
higher [7]. Middle-aged English adults tend to be healthier
than American adults of the same age range, according to
between-country differences in the prevalence of several
chronic diseases and average levels of disease biomarkers
[8]. While the biological processes underlying mortality risk
are not expected to differ between the two countries, some
predictive risk markers for mortality may differ based on
between-country differences in health care systems, health
behaviour distributions, early life exposures and health con-
ditions, and the social determinants of health [8].
We aimed to develop and validate an index to predict
10-year mortality in the general population aged 50 years
and older in England, using data from the English
Longitudinal Study of Ageing (ELSA). This index is
intended to be based on information readily ascertainable in
a brief patient–physician discussion and to correspond to
the existing American index, which was developed using
data from the Health and Retirement Study (HRS), the sis-
ter study to the ELSA [9, 10].
Methods
Design
This study was conducted in accordance with the recom-
mendations of the Transparent Reporting of a multivariable
prediction model for Individual Prognosis Or Diagnosis
(TRIPOD) statement [11]. Data were from 10,798 men
and women aged 50 years and older in Wave 1 (2002–03)
the population-based ELSA. The ELSA was established in
2002 based on a random stratiﬁed sample of households
participating in the Health Survey for England [10]. In the
ﬁrst wave of ELSA, 11,391 core participants completed
data collection (66% response rate). Of these, 10,798 con-
sented to the mortality follow-up and were included in this
study (94.8%). Data were collected biennially through
home-based face-to-face interviews. The London
Multicentre Research Ethics Committee granted ethical
approval for the ELSA (MREC/01/2/91), and informed
consent was obtained from all participants.
Measures
The outcome of interest was all-cause mortality through
March 2013. The National Health Service central data regis-
try supplied mortality data for all participants who con-
sented to the mortality follow-up. The mean follow-up
period was 9.4 years (standard deviation: 2.6; range: 0–11
years). Consistent with the corresponding HRS index, we
considered potential predictors of 10-year mortality in three
categories: sociodemographic factors, health behaviour and
comorbidity variables, and functional status variables.
Detailed descriptions of these measures are available online
in the Supplementary Material.
Statistical analysis
We closely followed the statistical analysis plan used to
develop mortality index by Lee et al. based on the HRS data
[5]. The full detailed statistical analysis plan is available online
in the Supplementary Methods. In brief, we randomly
divided the 10,798 eligible and consenting participants into
development (n = 5,377) and validation (n = 5,421) cohorts.
In the development cohort, a Cox regression model was built
to be robust to three selection strategies. Mortality risk point
scores were assigned to the predictors in the ﬁnal model by
dividing the regression coefﬁcient for each predictor by that
of the predictor most weakly associated with all-cause mor-
tality. Discrimination of the index was assessed using the
area under the receiver operating characteristic (ROC) curves
in the development and validation cohorts. Discrimination
was also assessed across subgroups of age, ethnicity and edu-
cation. A risk score–stratiﬁed Kaplan–Meier curve for all-
cause mortality through March 2013 was calculated for the
full cohort. The discriminatory capability of our model was
compared to that of the original American HRS model using
the chi-square test of equality of ROC areas. All statistical
analyses were conducted using StataSE 13.1 (StataCorp,
College Station, TX, USA).
Results
Supplementary Table 1 shows the characteristics of the
development and validation cohorts. Both cohorts were
comparable on all characteristics. Overall, 10-year mortality
was 24% (2,589/10,798). The unadjusted predictors of
mortality risk in the development cohort are shown in
Supplementary Table 2. All considered predictor variables
were associated with mortality risk in unadjusted analyses,
with the exception of body mass index (BMI). The ﬁnal 10-
item prediction model included the following variables: age,
sex, vigorous physical activity, smoking, cancer, chronic
lung disease, heart failure, difﬁculty preparing meals, difﬁ-
culty pushing or pulling large objects and difﬁculty walking
100 yards (Tables 1 and 2). The fewest number of points
achievable on the index is 0, corresponding to a woman
aged 50–59 years who engages in some vigorous physical
activity, does not smoke, has no diagnosis of cancer,
chronic lung disease, or heart failure, and who has no difﬁ-
culty preparing meals, pushing or pulling large objects or
walking 100 yards. The maximum number of points achiev-
able is 28.
Mortality rates ranged from 1.9% (6/323; development
cohort) and 1.5% (5/341; validation cohort) at the 0 point
level to 96.9% (95/98; development cohort) and 93.1%
(94/101; validation cohort) at the ≥16 point level
(Supplementary Table 3). Few participants scored above 16
on the index and mortality rates were similar at and above
this level; hence scores were collapsed at this point to
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maintain statistical power for the categorical analysis. The
index showed excellent discrimination, with ROC
area = 0.855 in the development cohort and ROC area =
0.859 in the validation cohort. Across speciﬁc population
subgroups, the index showed good discrimination in the
full cohort according to area under the ROC curve: 0.728
for ages 50–69 years, 0.679 for ages 70–79 years and 0.678
for ages ≥80 years; 0.902 for white adults and 0.846 for
non-white adults; 0.840 for those with no educational quali-
ﬁcations, 0.859 for those with intermediate-level education
and 0.846 for those with a higher degree. Figure 1 shows
the Kaplan–Meier curve for survival through March 2013
in the entire cohort by grouped risk points. Although the
HRS index showed no gross lack of ﬁt in the ELSA sample
(P = 0.166; Supplementary Table 4), it displayed signiﬁ-
cantly worse sensitivity and speciﬁcity for mortality than the
new index (test of equality of ROC areas: χ2 = 60.62,
P < 0.001; Supplementary Figure 1).
Discussion
This simple 10-item index shows excellent discrimination
and predictive capability for risk of 10-year mortality among
English adults aged 50 years and older. The items included
in the index are often collected in epidemiological studies
of older adults and should be easily ascertainable during a
brief patient–physician discussion. With slightly different
risk point items and weightings, this index shows slightly
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Table 1. Independent risk factors for 10-year mortality in the development cohort and points allocated
Risk factors Adjusted HRa (95% CI) Coefﬁcients Risk pointsb
Demographics
Age
60–64 1.72 (1.30–2.27) 0.560 1
65–69 3.33 (2.60–4.27) 1.310 3
70–74 6.15 (4.88–7.74) 2.029 5
75–79 10.29 (8.20–12.91) 2.767 7
80–84 17.37 (13.82–21.84) 3.583 9
≥85 26.93 (21.00–34.53) 4.492 12
Male 1.75 (1.56–1.96) 0.672 2
Health behaviours and comorbidities
No vigorous physical activity 1.64 (1.41–1.91) 0.545 1
Smoking 1.89 (1.63–2.19) 0.813 2
Cancer 1.53 (1.26–1.85) 0.535 1
Chronic lung disease 1.41 (1.19–1.67) 0.608 2
Heart failure 2.45 (1.66–3.61) 1.426 4
Functional status variables
Difﬁculty preparing meals 1.58 (1.28–1.94) 0.721 2
Difﬁculty pushing or pulling large objects 1.34 (1.16–1.55) 0.386 1
Difﬁculty walking 100 yards 1.44 (1.24–1.68) 0.534 1
HR, hazard ratio.
aAll variables in column are mutually adjusted.
bPoints calculated by dividing each beta coefﬁcient by the lowest beta coefﬁcient (difﬁculty pushing or pulling heavy objects) and rounding to the nearest integer
value.
Table 2. Ten-year mortality index for older adults in England
1. Age _________________________ 60–64: 1 point
65–69: 3 points
70–74: 5 points
75–79: 7 points
80–84: 9 points
≥85: 12 points
2. Sex (male/female) Male: 2 point
3. Do you take part in any sports or activities that are vigorous? (Y/N) No vigorous physical activity: 1 point
4. Do you smoke at all nowadays? (Y/N) Smoking: 2 points
5. Has a doctor ever told you that you have cancer or a malignant tumour (excluding minor skin cancers)? (Y/N) Cancer: 1 point
6. Has a doctor ever told you that you have chronic lung disease, such as chronic bronchitis or emphysema? (Y/N) Chronic lung disease: 2 point
7. Has a doctor ever told you that you have congestive heart failure? (Y/N) Heart failure: 4 points
8. Because of a health or memory problem, do you have any difﬁculty preparing a hot meal? (Y/N) Preparing meals: 2 points
9. Because of a health problem, do you have any difﬁculty pushing or pulling large objects like a living
room chair? (Y/N)
Pushing/pulling large objects: 1 point
10. Because of a health problem, do you have any difﬁculty walking 100 yards? (Y/N) Walking 100 yards: 1 point
Total points: _______
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improved sensitivity and speciﬁcity for 10-year mortality in
the English population over a similar index developed for
the older American population. This new mortality risk
index is similar to frailty indices that predict mortality such
as the Frailty Phenotype or the Frailty Index [12–14]; yet, it
includes additional mortality-speciﬁc risk factors (namely
age, sex and smoking status), is validated for use in the old-
er English population and harmonised with an existing
mortality risk index for the older American population.
This index may be useful for research, policy and clinical
purposes in England.
This new ELSA index and the original HRS index
assigned the same number of risk points to variables for
male, current smoking and lung disease. Both indices
included diagnoses of cancer (1 point ELSA, 2 points HRS)
and heart failure (4 points ELSA, 2 points HRS), difﬁculty
pushing and pulling large objects (1 point ELSA, 2 points
HRS) and difﬁculty walking 100 yards/several blocks (1
point ELSA, 2 points HRS). The ELSA index assigns a
greater weighting to older age, with scores going up to 12
points for being aged 85 years and older versus 7 points for
being aged 85 years and older in the HRS index. The ELSA
index additionally includes no vigorous physical activity (1
point) and having difﬁculty preparing a hot meal (2 points).
The HRS index additionally includes diabetes (1 point),
BMI < 25 (1 point) and having difﬁculty bathing or man-
aging ﬁnances (2 points each) [5]. The corresponding index
items of age, sex, smoking status, heart failure, cancer, lung
disease and difﬁculty walking make sense; the biological pro-
cesses underpinning mortality risk are not expected to differ
between the USA and England. Rather, differences in med-
ical systems between the two countries may be an ecological
contributor to some of the between-country differences we
observed in predictors of mortality [15].
In the USA, Medicare is available at a monthly premium
to American citizens aged 65 years and older who have
paid Medicare taxes through work for at least 10 years [16].
In England, health care through the NHS is free at the
point of care to adults of all ages [17]. In the USA, lack of
health insurance coverage is consistently associated with
increased risk of all-cause mortality and mortality due to
diseases amenable to health care among working age adults
[18–21]. Lack of adequate health insurance among some
HRS cohort members, particularly in the pre-Medicare age
group, may contribute to some observed differences in
mortality and its predictors between the ELSA and HRS
cohorts [19]. Uninsured patients with long-term chronic
conditions have worse health outcomes in the USA than
those with insurance [21]. Although the accumulated effect
of inadequate health insurance on late life mortality is less
well studied than mortality at working ages, it is plausible
that a lifetime lack of adequate health care access would
affect outcomes in later life, regardless of Medicare avail-
ability. The Affordable Care Act was introduced in 2010; its
potential long-term beneﬁts to population health have not
yet come to fruition. Other factors that may explain differ-
ences in the two indices could be differential rates of some
chronic conditions, such as diabetes [5, 22], and differential
effects of various social determinants of health between the
two countries [8].
Differences in the two indices with respect to BMI are
more difﬁcult to explain. BMI data in our cohort were miss-
ing at a higher rate than for other variables (33% missing;
3575/10798). We may have observed a lack of association
between BMI and mortality for this reason although BMI is
inversely associated with mortality only in adults older than
65 years [23, 24]. The ELSA cohort had a smaller proportion
of adults older than 65 years than the HRS cohort, so this
relatively weak predictor of mortality may have been more
relevant in the HRS cohort. Mortality rates were lower
among those with complete BMI data than in the full sample
for this study, indicating that our data may not reﬂect the full
distribution of BMI in the general population. This is a limi-
tation of our study, as our index might have shown even bet-
ter performance if BMI data were included. Regardless, the
index shows high predictive capability for mortality without
an objective BMI measurement, which might increase its
ease of use in settings when BMI data are unavailable.
Figure 1. Kaplan–Meier survival curve by grouped risk points.
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Our index is consistent with a recent index to predict 5-
year mortality among adults aged 40–70 years in the UK
Biobank [25]. Using data on 498,103 UK Biobank partici-
pants, Ganna and Inglesson developed 5-year mortality risk
indices with 11 items for men and 13 items for women.
They assessed 655 measurements for potential associations
with mortality, while we aimed to develop and validate an
index for an older segment of the population based on an a
priori selected set of predictors. Similar methods were used
in both studies, with concordant risk index items of age,
diagnoses of cancer and heart conditions, and smoking
[25]. The Biobank index includes regular pace of walking,
while ours includes difﬁculty walking; their index addition-
ally includes self-rated health and diagnosis of diabetes,
along with car ownership and number of household mem-
bers in men, number of live births in women and receipt of
state beneﬁts in men and women [25]. Each index has spe-
ciﬁc advantages. The Biobank Index is validated to predict
5-year risk of mortality among English adults aged 40–70
years, while the present ELSA index is validated to predict
10-year risk of mortality among adults aged 50 years and
older, including those older than 70 years. Both indices are
likely to be useful across research, policy and clinical set-
tings for their respective purposes.
Our index has limitations. All variables were assessed
through self-report in an in-person study interview and may
be subject to recall error or bias. However, patient reports of
chronic disease diagnoses and functional limitations have
shown adequate validity in other similar samples [26, 27].
With the exception of BMI and history of falls, which was
only measured among those aged 60 years and older, less
than 2% of data were missing for all variables. There are
likely to be other age-related risk factors for mortality not
included in our model, as indicated by the large risk scores
attributable to older ages, although a more complex model
would reduce its practicality for applied use. Namely, ageing-
related cognitive decline is a mortality risk factor that was
excluded to avoid imposing the need for a cognitive assess-
ment to be conducted for the index to be operational. The
index may be statistically over-powered with respect to indi-
vidual prognostication; so follow-up validation for individual
prognoses within other prospective studies is needed.
Follow-up for observed mortality with the HRS index has
shown its predictions are valid in the American setting [28].
We did not have data on speciﬁc causes of death, which
could be examined in relation to this index in the future.
Finally, although older adults who were in permanent institu-
tional care were excluded, the ELSA cohort is representative
of the older population of England aged 50 years and older,
including cognitively or physically impaired adults and those
in hospital or temporary care [10].
In conclusion, we have developed and validated a simple
yet comprehensive index to predict 10-year mortality risk
among adults aged 50 years and older in England. Given
that several ageing cohort studies exist in England (e.g. the
ELSA, the Whitehall II cohort, the 1946 British Birth
Cohort and the UK Biobank, as its sample ages), this index
should be useful for investigators using the English data
sets to study health during ageing, although it requires val-
idation for individual prognostication in studies outside of
the ELSA. The index includes mortality risk factors that
should be easily discernible in a brief patient–physician dis-
cussion and are often available in epidemiological studies.
The simplicity of the index is advantageous for accurate
prediction of mortality risk when biomarker data are not
available, and it should prove useful for several purposes.
Key points
• Ten-year mortality risk can be accurately predicted by 10
simple risk factors in older English adults.
• In this sample, 95% of adults with all 10 risk factors die
within 10 years.
• This index should be useful for epidemiological research
and clinical decision-making for older adults.
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